Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection. - Wikidata - wikimedia - TriplyDB

Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection.

Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection.

http://www.wikidata.org/entity/Q34352022

about

Engineering of routes to heparin and related polysaccharides Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma Toxoplasma gondii inhibits mast cell degranulation by suppressing phospholipase Cγ-mediated Ca(2+) mobilization.Loss of Serglycin Promotes Primary Tumor Growth and Vessel Functionality in the RIP1-Tag2 Mouse Model for Spontaneous Insulinoma Formation.Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice Serglycin: at the crossroad of inflammation and malignancy.The Roles of Mast Cells in Parasitic Protozoan Infections.

P2860

Q27013519-CD552AB2-FDB6-4E56-A738-862DEC831DA9 Q28552442-9C5B54C6-A772-4184-8C37-9594E9726E64 Q30541177-F8E03143-12EE-4400-82CC-39D8101A3AE1 Q35610679-8FEBC395-A901-4F50-BAC2-CE0E93FABA55 Q36042295-1A734A98-3F4E-41A5-B8D2-9DD45CA348E1 Q37467048-06DE0DE0-E3D3-44CF-8488-D7885D749482 Q37739125-91A926D2-53A9-4B5F-8740-F0C6167DF46D

P2860

Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection.

http://www.wikidata.org/entity/Q34352022

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Serglycin-independent release ...... o Toxoplasma gondii infection.

@ast

Serglycin-independent release ...... o Toxoplasma gondii infection.

@en

Serglycin-independent release ...... o Toxoplasma gondii infection.

@nl

type

label

Serglycin-independent release ...... o Toxoplasma gondii infection.

@ast

Serglycin-independent release ...... o Toxoplasma gondii infection.

@en

Serglycin-independent release ...... o Toxoplasma gondii infection.

@nl

prefLabel

Serglycin-independent release ...... o Toxoplasma gondii infection.

@ast

Serglycin-independent release ...... o Toxoplasma gondii infection.

@en

Serglycin-independent release ...... o Toxoplasma gondii infection.

@nl

P1433

Q34352022-5F2152F4-2783-4267-8631-31BB03397E07

P1476

Q34352022-26A8C408-55A5-438E-83A9-C6438A4CF5FE

P2093

Q34352022-0998F27D-EF03-4571-B963-BE89D9420AA2

Q34352022-5BEB652E-789A-4D88-A2F9-F0137A5F1FAF

Q34352022-B9431349-EBFF-4D9E-886C-7650C1CCC414

Q34352022-BFD472F6-74D5-47C6-891A-371C65C7668F

P2860

Q34352022-070D6DCF-AA69-4258-A34D-7D809FBACBAA

Q34352022-0F81B648-7B66-4B8A-A8C2-1E813F4B0705

Q34352022-0F9CE6C4-4F27-4B9B-874B-2286014068DF

Q34352022-10948964-45CF-49BA-B13A-BD80D6C752BE

Q34352022-14C52F29-C04B-452F-9E5B-9AE226D74B35

Q34352022-164D5454-62D0-4D9D-8DC5-BB9FA46C0C3C

Q34352022-1768EC76-639B-4895-B64F-AB8A98A8A73A

Q34352022-21E49354-BBF9-4AE8-BC7C-A25A3A332065

Q34352022-29361697-A44B-4BC1-9A02-C547A309860E

Q34352022-2B5535BC-F21B-4727-9408-A8ACA5BAB007

P304

Q34352022-1AF420F5-208E-4C49-A50F-DE3B527FE5D7

P31

Q34352022-A29C32AE-C84D-4D2D-B9FE-41EED41E3911

P356

Q34352022-8CFA32F3-F8F7-4D7D-A0C8-A15D000C4767

P407

Q34352022-DB185460-A14B-4571-AB2E-8A93F067E70B

P433

Q34352022-8AA5F121-2052-4CC1-9ED9-2CF0A6B99A3E

P478

Q34352022-0FF5AE6E-5B40-4403-BDCA-6DFFC2F0DDC7

P50

Q34352022-AFD67C21-F213-4A2E-B9B7-71A4A42B6CCB

P577

Q34352022-E1924F52-9EAD-473C-82AA-CFDCDB9DACAC

P698

Q34352022-716A1578-A589-4985-B357-1BAC05CC9DB4

P921

Q34352022-2A1A8116-981A-4C28-848D-FC0E9FB13296

Q34352022-FF3F1D2F-54CE-41C4-B5DD-3D0E00F1A459

P932

Q34352022-59EF37E7-A12E-464F-A102-FBCFD7B01C9F

P356

JBC.M110.118471

P1433

Journal of Biological Chemistry

P1476

Serglycin-independent release ...... o Toxoplasma gondii infection.

@en

P2093

Anna Lundén

http://www.w3.org/2001/XMLSchema#string

Dorothe Spillmann

http://www.w3.org/2001/XMLSchema#string

Magnus Åbrink

http://www.w3.org/2001/XMLSchema#string

Osama Sawesi

http://www.w3.org/2001/XMLSchema#string

P2860

Serglycin--structure and biology

Serglycin is essential for maturation of mast cell secretory granule

Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage

Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme

A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components

Heparin is essential for the storage of specific granule proteases in mast cells

Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin

Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection

Mast cells promote homeostasis by limiting endothelin-1-induced toxicity.

Mast cells can enhance resistance to snake and honeybee venoms.

P304

38005-38013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.118471

http://www.w3.org/2001/XMLSchema#string

P407

P433

49

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P50

Sara Wernersson

P577

2010-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20864536

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

P932

2992234

http://www.w3.org/2001/XMLSchema#string